COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,235 Articles (22,733 medRxiv, 8,502 bioRxiv)

Most recent first Previous |  Page 2166: Articles 21651-21660  | Next

COVID-19 in Italy: targeted testing as a proxy of limited health care facilities and a key to reducing hospitalization rate and the death toll.
Bandyopadhyay, A., Schips, M., Mitra, T., Khailaie, S., Binder, S., Meyer-Hermann, M.
10.1101/2020.10.12.20211169 — Posted: 2020-10-14
Prioritisation of population groups with the most interactions for COVID-19 vaccination can substantially reduce total fatalities
Rodriguez, J., Paton, M., Acuna, J. M.
10.1101/2020.10.12.20211094 — Posted: 2020-10-14
Understanding the Los Angeles County Coronavirus Epidemic: The Critical Role of Intrahousehold Transmission
Harris, J. E.
10.1101/2020.10.11.20211045 — Posted: 2020-10-14
Derivation and validation of a triage tool for acutely ill adults with suspected COVID-19: The PRIEST observational cohort study
Goodacre, S., Thomas, B., Sutton, L., Burnsall, M., Lee, E., Bradburn, M., Loban, A., Waterhouse, S., Simmonds, R., Biggs, C., Marincowitz, C., Schutter, J., Connelly, S., Sheldon, E., Hall, J., Young, E., Bentley, A., Challen, K., Fitzsimmons, C., Harris, T., Lecky, F., Lee, A., Maconochie, I., Walter, D.
10.1101/2020.10.12.20209809 — Posted: 2020-10-14 Discussion: Onsite
High and increasing prevalence of SARS-CoV-2 swab positivity in England during end September beginning October 2020: REACT-1 round 5 updated report
Riley, S., Ainslie, K. E. C., Eales, O., Walters, C. E., Wang, H., Atchison, C. J., Fronterre, C., Diggle, P. J., Ashby, D., Donnelly, C. A., Cooke, G., Barclay, W., Ward, H., Darzi, A., Elliott, P.
10.1101/2020.10.12.20211227 — Posted: 2020-10-14
School education during the SARS-CoV-2 pandemic - Which concept is safe, feasible and environmentally sound?
Kähler, C. J., Fuchs, T., Mutsch, B., Hain, R.
10.1101/2020.10.12.20211219 — Posted: 2020-10-14 Discussion: Onsite
CORRELATION BETWEEN SARS-COV-2 ANTIBODY SCREENING BY IMMUNOASSAY AND NEUTRALIZING ANTIBODY TESTING
MENDRONE-JUNIOR, A., DINARDO, C., FERREIRA, S., NISHIA, A., SALLES, N., ALMEIDA-NETO, C., HAMASAKI, D., FACINCANI, T., ALVES, L., MACHADO, R., ARAUJO, D., DURIGON, E., ROCHA, V., SABINO, E.
10.1101/2020.10.11.20210005 — Posted: 2020-10-14
Scrutiny for Child Abuse and Neglect During the COVID-19 Pandemic
Catillon, M., Mandl, K. D.
10.1101/2020.10.12.20210997 — Posted: 2020-10-14
COVID-CT-Mask-Net: Prediction of COVID-19 from CT Scans Using Regional Features
Ter-Sarkisov, A.
10.1101/2020.10.11.20211052 — Posted: 2020-10-14
Network Graph Representation of COVID-19 Scientific Publications to Aid Knowledge Discovery
Cernile, G., Heritage, T., Sebire, N., Gordon, B., Schwering, T., Kazemlou, S., Borecki, Y.
10.1101/2020.10.12.20211342 — Posted: 2020-10-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).